Erik Snorre Øfjord

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer

Per Eystein Lønning, Jürgen Geisler, Lars Erik Krag et al. · Journal of Clinical Oncology · 2005 · 293 citations · Full text

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 164 citations

Bone Disease, Osteopathy, Loft Extension Study +10

Effect of experimental tooth movement on periodontal and pulpal blood flow

Steinar Kvinnsland, Karin J. Heyeraas, Erik Snorre Øfjord · European Journal of Orthodontics · 1989 · 103 citations

Engineering, Biomedical Engineering, Blood Flow +16

Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: A randomised, placebo-controlled study

Jürgen Geisler, Per Eystein Lønning, Lars Erik Krag et al. · European Journal of Cancer · 2006 · 100 citations

Breast Oncology, Lipid Metabolism, Early Breast Cancer +10

Nutritional Regulation of Bile Acid Metabolism Is Associated with Improved Pathological Characteristics of the Metabolic Syndrome

Bjørn Liaset, Qin Hao, Henry Jørgensen et al. · Journal of Biological Chemistry · 2011 · 70 citations · Full text